Latest news from Cancer Research Institute and the Ludwig Cancer Research on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/ludwig-cancer-research-and-cancer-research-institute-launch-clinical-trial-combining-virotherapy-and-immunotherapy-to-treat-advanced-colorectal-and-ovarian-cancers2/?sc=rsin /articles/ludwig-cancer-research-and-cancer-research-institute-launch-clinical-trial-combining-virotherapy-and-immunotherapy-to-treat-advanced-colorectal-and-ovarian-cancers2/?sc=rsin Wed, 11 Jul 2018 10:00:59 EST A clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI(r) (durvalumab) for advanced ovarian and colorectal cancers has been initiated. Cancer Research Institute and the Ludwig Cancer Research